[(1R)-1-(4-oxo-3H-quinazolin-2-yl)ethyl] 4-oxo-4-(5-phenyl-3,4-dihydropyrazol-2-yl)butanoate
C23H22N4O4 — CID 135766837
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(1R)-1-(4-oxo-3H-quinazolin-2-yl)ethyl] 4-oxo-4-(5-phenyl-3,4-dihydropyrazol-2-yl)butanoate
[(1R)-1-(4-oxo-3H-quinazolin-2-yl)ethyl] 4-oxo-4-(5-phenyl-3,4-dihydropyrazol-2-yl)butanoate (PubChem CID 135766837) has the molecular formula C23H22N4O4 and a molecular weight of 418.45 g/mol. Its IUPAC name is [(1R)-1-(4-oxo-3H-quinazolin-2-yl)ethyl] 4-oxo-4-(5-phenyl-3,4-dihydropyrazol-2-yl)butanoate.
Molecular Properties
| Compound Name | [(1R)-1-(4-oxo-3H-quinazolin-2-yl)ethyl] 4-oxo-4-(5-phenyl-3,4-dihydropyrazol-2-yl)butanoate |
|---|---|
| PubChem CID | 135766837 |
| Molecular Formula | C23H22N4O4 |
| Molecular Weight | 418.45 g/mol |
| Exact Mass | 418.16 |
| IUPAC Name | [(1R)-1-(4-oxo-3H-quinazolin-2-yl)ethyl] 4-oxo-4-(5-phenyl-3,4-dihydropyrazol-2-yl)butanoate |
| SMILES | C[C@@H](OC(=O)CCC(=O)N1CCC(c2ccccc2)=N1)c1nc2ccccc2c(=O)[nH]1 |
| InChI | InChI=1S/C23H22N4O4/c1-15(22-24-19-10-6-5-9-17(19)23(30)25-22)31-21(29)12-11-20(28)27-14-13-18(26-27)16-7-3-2-4-8-16/h2-10,15H,11-14H2,1H3,(H,24,25,30)/t15-/m1/s1 |
| InChIKey | UFNDXNFYFOVLHA-OAHLLOKOSA-N |
| XLogP | 2.94 |
| TPSA | 104.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 418.45 |
| LogP ≤ 5 | 2.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135766837 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.